UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions

Annals of oncology, 2003-09, Vol.14 (9), p.1430-1437

2003

Volltextzugriff (PDF)

Disposition of Glucosinolates and Sulforaphane in Humans After Ingestion of Steamed and Fresh Broccoli

Nutrition and cancer, 2000-01, Vol.38 (2), p.168-178

2000

Volltextzugriff (PDF)

A phase I and pharmacokinetic study of oxaliplatin and bortezomib: activity, but dose-limiting neurotoxicity

Cancer chemotherapy and pharmacology, 2013-11, Vol.72 (5), p.1073-1078

2013

Volltextzugriff (PDF)

Proteasome Inhibition With Bortezomib (PS-341): A Phase I Study With Pharmacodynamic End Points Using a Day 1 and Day 4 Schedule in a 14-Day Cycle

Journal of clinical oncology, 2005-09, Vol.23 (25), p.6107-6116

2005

Volltextzugriff (PDF)

Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations

Oncogene, 2008-05, Vol.27 (22), p.3201-3210

2008

Volltextzugriff (PDF)

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

International journal of radiation oncology, biology, physics, 2004-03, Vol.58 (3), p.862-870

2004

Volltextzugriff (PDF)

Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer

Gynecologic oncology, 2006-12, Vol.103 (3), p.783-792

2006

Volltextzugriff (PDF)

Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen

Journal of clinical oncology, 1994-03, Vol.12 (3), p.553-559

1994

Volltextzugriff (PDF)

Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines

Clinical cancer research, 2003-03, Vol.9 (3), p.1145-1154

2003

Volltextzugriff (PDF)

Phase I Clinical and Pharmacokinetic Study of BMS-247550, a Novel Derivative of Epothilone B, in Solid Tumors

Clinical cancer research, 2004-02, Vol.10 (4), p.1289-1298

2004

Volltextzugriff (PDF)

Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study

Clinical cancer research, 1997-08, Vol.3 (8), p.1245-1252

1997

Volltextzugriff (PDF)

Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan

Clinical cancer research, 1998-03, Vol.4 (3), p.545-557

1998

Volltextzugriff (PDF)

Pharmacokinetics of the Cardioprotector ADR-529 (ICRF-187) in Escalating Doses Combined With Fixed-Dose Doxorubicin

JNCI : Journal of the National Cancer Institute, 1992-11, Vol.84 (22), p.1725-1730

1992

Volltextzugriff (PDF)

Chlorambucil pharmacokinetics and DNA binding in chronic lymphocytic leukemia lymphocytes

Cancer research (Chicago, Ill.), 1989-02, Vol.49 (3), p.554-559

1989

Volltextzugriff (PDF)

Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma

Cancer, 2003-05, Vol.97 (S9), p.2363-2373

2003

Volltextzugriff (PDF)

Randomized, placebo-controlled trial of dietary supplementation of alpha-tocopherol on mutagen sensitivity levels in melanoma patients: a pilot trial

Melanoma research, 2002-02, Vol.12 (1), p.83-90

2002

Volltextzugriff (PDF)

Thalidomide in Advanced Hepatocellular Carcinoma with Optional Low-Dose Interferon- alpha 2a upon Progression

The oncologist (Dayton, Ohio), 2005-10, Vol.10 (9), p.718-727

2005

Volltextzugriff (PDF)

Phase I Study of Combined Pegylated Liposomal Doxorubicin with Protracted Daily Topotecan for Ovarian Cancer

Clinical cancer research, 2005-08, Vol.11 (16), p.5912-5919

2005

Volltextzugriff (PDF)

Activity and Pharmacodynamics of 21-Day Topotecan Infusion in Patients With Ovarian Cancer Previously Treated With Platinum-Based Chemotherapy

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2553-2561

1999

Volltextzugriff (PDF)

Phase I Trial of Escalating Doses of Paclitaxel Plus Doxorubicin and Dexrazoxane in Patients With Advanced Breast Cancer

Journal of clinical oncology, 1999-03, Vol.17 (3), p.880-886

1999

Volltextzugriff (PDF)

Relationship of dehydroascorbic acid transport to cell lineage in lymphocytes from normal subjects and patients with chronic lymphocytic leukemia

Cancer research (Chicago, Ill.), 1985-12, Vol.45 (12), p.6507-6512

1985

Volltextzugriff (PDF)

Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts

Cancer research (Chicago, Ill.), 2001-04, Vol.61 (7), p.2996-3001

2001

Volltextzugriff (PDF)

Purification and characterization of actin from normal and chronic lymphocytic leukemia lymphocytes

Cancer research (Chicago, Ill.), 1983-10, Vol.43 (10), p.4966-4973

1983

Volltextzugriff (PDF)

Phase I and pharmacologic study of i.p. 9-aminocamptothecin given as six fractions over 14 days

Anti-cancer drugs, 2002-09, Vol.13 (8), p.819-825

2002

Volltextzugriff (PDF)

Intraperitoneal Topoisomerase-I Inhibitors: Preliminary Findings with 9-Aminocamptothecin

Annals of the New York Academy of Sciences, 2000-01, Vol.922 (1), p.178-187

2000

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(46)

Sprache

Englisch
(46)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(46)
Science & Technology
(46)
Humans
(42)
Female
(23)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Adult
(20)
Male
(19)
Middle Aged
(19)
Aged
(18)
Pharmacology. Drug Treatments
(16)
Antineoplastic Agents
(15)
Animals
(11)
Biochemistry & Molecular Biology
(10)
Cell Biology
(10)
Multidisciplinary Sciences
(10)
Science & Technology - Other Topics
(10)
Neoplasms - Drug Therapy
(9)
Antineoplastic Agents - Administration & Dosage
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions

Disposition of Glucosinolates and Sulforaphane in Humans After Ingestion of Steamed and Fresh Broccoli

A phase I and pharmacokinetic study of oxaliplatin and bortezomib: activity, but dose-limiting neurotoxicity

Proteasome Inhibition With Bortezomib (PS-341): A Phase I Study With Pharmacodynamic End Points Using a Day 1 and Day 4 Schedule in a 14-Day Cycle

Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer

Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen

Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines

Phase I Clinical and Pharmacokinetic Study of BMS-247550, a Novel Derivative of Epothilone B, in Solid Tumors

Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study

Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan

Pharmacokinetics of the Cardioprotector ADR-529 (ICRF-187) in Escalating Doses Combined With Fixed-Dose Doxorubicin

Chlorambucil pharmacokinetics and DNA binding in chronic lymphocytic leukemia lymphocytes

Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma

Randomized, placebo-controlled trial of dietary supplementation of alpha-tocopherol on mutagen sensitivity levels in melanoma patients: a pilot trial

Thalidomide in Advanced Hepatocellular Carcinoma with Optional Low-Dose Interferon- alpha 2a upon Progression

Phase I Study of Combined Pegylated Liposomal Doxorubicin with Protracted Daily Topotecan for Ovarian Cancer

Activity and Pharmacodynamics of 21-Day Topotecan Infusion in Patients With Ovarian Cancer Previously Treated With Platinum-Based Chemotherapy

Phase I Trial of Escalating Doses of Paclitaxel Plus Doxorubicin and Dexrazoxane in Patients With Advanced Breast Cancer

Relationship of dehydroascorbic acid transport to cell lineage in lymphocytes from normal subjects and patients with chronic lymphocytic leukemia

Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts

Purification and characterization of actin from normal and chronic lymphocytic leukemia lymphocytes

Phase I and pharmacologic study of i.p. 9-aminocamptothecin given as six fractions over 14 days

Intraperitoneal Topoisomerase-I Inhibitors: Preliminary Findings with 9-Aminocamptothecin

Aktive Filter

Suchergebnisse filtern